AX'S CONSULTING
@AXSCONSULT
Our mission: be the voice of the market access stakeholder in healthcare
You might like
How RWE can facilitate market access: easier said than done linkedin.com/pulse/how-rwe-…
linkedin.com
How RWE can facilitate market access: easier said than done
The regulatory environment in the USA and Europe is highly favourable to orphan drugs. The options of accelerated pathways and/or conditional approval allows products to be developed in a shorter...
Exciting and ambitious initiative. Curious to learn how different stakeholder perspectives will be accommodated, bot…lnkd.in/gYHjuZy
Takeda to buy cancer drug maker Ariad in $5.2bn pact lnkd.in/g_ub_7b
First project of the new year approved on January 6th. I'm looking forward to an exciting 2017! #lovemyjob
@NHSEngland proposed new approach to establishing value for money of specialised meds: worth taking a look...tinyurl.com/jyxvyds #HTA
German health insurers to start negotiating price discounts once a drug surpasses sales of about €250 million | on.wsj.com/1T2HG1q #HTA
wsj.com
Germany Mulls Limiting Prices Drug Firms Can Charge to Health System
The German government is considering limiting the price that drug companies can charge the country’s health care system for their latest medicines—a move that would curtail a lucrative, one-year...
Belgian reimbursement bodies keen to look more at PRO's than mere survival benefits in oncology. Inspired by concern for patient or budget?
David against Goliath. More to follow for sure. lnkd.in/edr2FTg
Worth watching this talk: How algorithms and the power of the consumer can change the way healthcare is delivered.…lnkd.in/bbUGzZr
Pricing databases: will that help? If price discounts are confidential, these will not show up, for price referencing. #ISPORAmst
Join us for drinks, a sandwich and new insights on Monday and Tuesday 12-2pm, away from the crowds. Hospitality suite E107. #Isporamsterdam
"We do not have healthcare systems, we have sick care systems". Chris Viehbacher sums it up perfectly. But not just in EU. #EUHealth
Payer-provider collaborations seek to answer proton beam therapy questions fiercehealthpayer.com/story/payer-pr…
New Health Systems in Transition (HiT) report for #Germany discusses challenges for the future goo.gl/5bJhTZ
Prof Joep Lange, world authority in HIV, one of the victims of #MH17. Great loss to medical community.
Novartis plans to test Alzheimer's drugs in patients without symptoms. Just wonder how payers will react to this. fiercebiotech.com/story/novartis…
Very interesting: ASCO is the newest market access stakeholder for cancer treatments. Can have far reaching impact. fiercepharmamarketing.com/story/asco-pla…
Big data and stratified medicine: core issues summarised in a presentation by OHE's Towse ow.ly/tZkZl #caredata #NHS
United States Trends
- 1. Bill Belichick N/A
- 2. Bill Polian N/A
- 3. #TheMaskedSinger N/A
- 4. Hall of Fame N/A
- 5. Brady N/A
- 6. HOFer N/A
- 7. Spygate N/A
- 8. NFL HOF N/A
- 9. Webb N/A
- 10. The HOF N/A
- 11. #DelcyPorLaPaz N/A
- 12. #DelcyConMiguelCabrera N/A
- 13. Derrick Moore N/A
- 14. Kraft N/A
- 15. 8 Super Bowls N/A
- 16. Terrell Owens N/A
- 17. Iowa N/A
- 18. Joe Lombardi N/A
- 19. #drwfirstgoal N/A
- 20. Holocaust N/A
Something went wrong.
Something went wrong.